Johnson & Johnson is an American multinational healthcare company specializing in pharmaceuticals and medical technologies.

Morristown-based Sanofi will be the latest U.S. drugmaker to inject billions of dollars into domestic operations and American manufacturing.

ZURICH (Reuters) - Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ... while Eli Lilly and Johnson & Johnson also ...

IBM on Monday announced that it will invest $150 billion in U.S. manufacturing to "fuel the economy." The investment will include more than ... Johnson & Johnson's plan to invest $55 billion ...

Our resiliency is a testament to what makes us unique ... pharmaceutical manufacturing capacity. Johnson & Johnson is already investing more than $55 billion over the next four years in boosting ...

Since the start of President Trump's second term in office, a number of corporations have announced plans ... are located." Johnson & Johnson is planning to invest more than $55 billion in new ...

Johnson & Johnson and Novartis are investing in ... these investments. It plans to spend over $55 billion in the U.S. over the next four years, which is 25% more than it spent in the previous ...

[ZURICH] Roche said on Tuesday (Apr 22) it would invest US$50 billion in the United States over the next five years, creating more than 12,000 new jobs ... while Eli Lilly and Johnson & Johnson also ...

Roche has announced a $50 billion ... export more medicines from the U.S. than it imports, reinforcing the company's commitment to U.S. innovation and growth. This development follows similar U.S.

He acknowledged feeling “a little bit” surprised to see the company’s investment included on the White House list, which has “given us ... Johnson & Johnson’s plans to spend $55 billion ...

Swiss pharmaceutical giant Roche plans to invest $50 billion in the U.S. over the next five years, the latest major spending commitment by a big drugmaker as the industry faces President Trump’s ...